Infectious Disease Control
Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive FDA Emergency Use Authorization
- Ortho's VITROS® SARS-CoV-2 Antigen Test is the first high-volume COVID-19 antigen test to receive Food and Drug Administration (FDA) Emergency Use Authorization (EUA). - With utility for mass-scale testing and same-day results for labs, Ortho's latest COVID-19 solution can run up to 130 tests ...
2021-01-13 03:13
1649
Guide Sensmart Launches New Guide QT Series IR Fever Warning System for Temperature Measurement featuring 5-minute Easy Installation
WUHAN, China, Jan. 13, 2021 /PRNewswire/ -- On December 28, 2020, China's leading company in epidemic prevention and temperature measurement, launched a new fever screening product: the Guide QT Series IR Fever Warning System with infrared thermal imaging and an automatic temperature measuremen...
2021-01-13 01:47
7232
IKEUCHI Launches New Fogging Device for Quick, Easy and Effective Disinfection
OSAKA, Japan, Jan. 12, 2021 /PRNewswire/ -- H. IKEUCHI & CO., LTD., a leading manufacturer of industrial and commercial spray nozzles, headquartered inJapan, has launched full-scale sales of a backpack disinfection device dubbed "Dry-Fog HIGHNOW (R)." Logo: https://kyodonewsprwire.jp/prwfile/re...
2021-01-12 16:00
1426
PT Mowilex to Screen Its Workers with COVID-19 Tests from Abbott
JAKARTA, Indonesia, Jan. 12, 2021 /PRNewswire/ -- Indonesian paint manufacturer PT Mowilex is safeguarding workers' health by purchasing COVID-19 diagnostic tests from U.S. health care company Abbott. PT Mowilex will roll out an aggressive testing program to enhance distancing and hygiene protoco...
2021-01-12 14:43
6037
Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients
SUZHOU, China, Jan. 10, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the clinical trial of Proxalutamide for the treatment of COVID-19 patients. The investigator initiated trial conducted by Dr.Andy Goren and Dr. Flávio Adsuara C...
2021-01-10 16:55
3820
Medical Waste Management Inherits a Multi-billion Dollar Opportunity from the Ongoing Pandemic
Asia-Pacific presents immense growth opportunities for medical waste management market participants as regulations mature and are thoroughly enforced, says Frost & Sullivan SANTA CLARA, Calif., Jan. 7, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis,Growth Opportunities in the Medical Wa...
2021-01-07 21:10
2404
KAIST Mobile Clinic Module to Fill Negative Pressure Ward Shortage
DAEJEON, South Korea, Jan. 6, 2021 /PRNewswire/ -- A team from KAIST has developed a low-cost and ready-for-rapid-production negative pressure room called a Mobile Clinic Module (MCM). The MCM is expandable, moveable, and easy to store through a combination of negative pressure frames, air tents...
2021-01-07 12:00
2071
KAIST Mobile Clinic Module to Relieve Demand for Negative Pressure Beds
DAEJEON, South Korea, Jan. 6, 2021 /PRNewswire/ -- A KAIST team has developed a low-cost and ready-for-rapid-production negative pressure room called a Mobile Clinic Module (MCM). The MCM expects to quickly meet the high demand for negative pressure beds in the nation and eventually many other c...
2021-01-07 12:00
1825
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18
- DNA immunotherapy candidate VGX-3100 demonstrated clinically significant reduction of HPV-16/18-associated precancerous vulvar lesions in 63% of treated participants six months after treatment - Phase 2 results indicate that VGX-3100 can be a safe, tolerable and efficacious adjunct to current ...
2021-01-06 21:00
4538
INOVIO and Advaccine Announce Exclusive Partnership To Commercialize COVID-19 DNA Vaccine Candidate, INO-4800, in Greater China
PLYMOUTH MEETING, Pa. and SUZHOU, China, Jan. 4, 2021 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou Co., Ltd. ("A...
2021-01-04 21:00
5264
Week's Top Stories
Most Reposted
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 278 media titles]
2025-12-26 12:55ACEN completes transition to 100% renewable energy
[Picked up by 273 media titles]
2025-12-29 18:53Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 273 media titles]
2025-12-30 20:12
CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 263 media titles]
2025-12-29 09:00
ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange
[Picked up by 259 media titles]
2025-12-29 14:27